BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35964258)

  • 1. Nm23-H1 induces apoptosis in primary effusion lymphoma cells via inhibition of NF-κB signaling through interaction with oncogenic latent protein vFLIP K13 of Kaposi's sarcoma-associated herpes virus.
    Mohanty S; Kumar A; Das P; Sahu SK; Mukherjee R; Ramachandranpillai R; Nair SS; Choudhuri T
    Cell Oncol (Dordr); 2022 Oct; 45(5):967-989. PubMed ID: 35964258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.
    Hunte R; Alonso P; Thomas R; Bazile CA; Ramos JC; van der Weyden L; Dominguez-Bendala J; Khan WN; Shembade N
    PLoS Pathog; 2018 Apr; 14(4):e1006968. PubMed ID: 29698475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice.
    Ahmad A; Groshong JS; Matta H; Schamus S; Punj V; Robinson LJ; Gill PS; Chaudhary PM
    Cancer Biol Ther; 2010 Nov; 10(10):1033-40. PubMed ID: 20818173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-κB.
    Gopalakrishnan R; Matta H; Chaudhary PM
    Clin Cancer Res; 2013 Sep; 19(18):5016-26. PubMed ID: 23881928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A computational profiling of changes in gene expression and transcription factors induced by vFLIP K13 in primary effusion lymphoma.
    Punj V; Matta H; Chaudhary PM
    PLoS One; 2012; 7(5):e37498. PubMed ID: 22624040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways.
    An J; Sun Y; Sun R; Rettig MB
    Oncogene; 2003 May; 22(22):3371-85. PubMed ID: 12776188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
    Paul AG; Chandran B; Sharma-Walia N
    Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A20 is induced by Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 and blocks K13-induced nuclear factor-kappaB in a negative feedback manner.
    Matta H; Gopalakrishnan R; Punj V; Yi H; Suo Y; Chaudhary PM
    J Biol Chem; 2011 Jun; 286(24):21555-64. PubMed ID: 21531730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.
    Sakakibara S; Espigol-Frigole G; Gasperini P; Uldrick TS; Yarchoan R; Tosato G
    Oncogene; 2013 Mar; 32(10):1223-32. PubMed ID: 22525270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma.
    Mohanty S; Kumar A; Das P; Sahu SK; Choudhuri T
    Apoptosis; 2017 Sep; 22(9):1098-1115. PubMed ID: 28653223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IKKγ-Mimetic Peptides Block the Resistance to Apoptosis Associated with Kaposi's Sarcoma-Associated Herpesvirus Infection.
    Briggs LC; Chan AWE; Davis CA; Whitelock N; Hotiana HA; Baratchian M; Bagnéris C; Selwood DL; Collins MK; Barrett TE
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
    Smith CG; Kharkwal H; Wilson DW
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma-associated herpesvirus oncoprotein K13 protects against B cell receptor-induced growth arrest and apoptosis through NF-κB activation.
    Graham C; Matta H; Yang Y; Yi H; Suo Y; Tolani B; Chaudhary PM
    J Virol; 2013 Feb; 87(4):2242-52. PubMed ID: 23236068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for MALT1 activity in Kaposi's sarcoma-associated herpes virus latency and growth of primary effusion lymphoma.
    Bonsignore L; Passelli K; Pelzer C; Perroud M; Konrad A; Thurau M; Stürzl M; Dai L; Trillo-Tinoco J; Del Valle L; Qin Z; Thome M
    Leukemia; 2017 Mar; 31(3):614-624. PubMed ID: 27538487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP).
    Matta H; Chaudhary PM
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9399-404. PubMed ID: 15190178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1.
    Nakayama R; Ueno Y; Ueda K; Honda T
    Oncogene; 2019 May; 38(22):4340-4351. PubMed ID: 30770900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma associated herpesvirus encoded viral FLICE inhibitory protein K13 activates NF-κB pathway independent of TRAF6, TAK1 and LUBAC.
    Matta H; Gopalakrishnan R; Graham C; Tolani B; Khanna A; Yi H; Suo Y; Chaudhary PM
    PLoS One; 2012; 7(5):e36601. PubMed ID: 22590573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells.
    Higashi C; Saji C; Yamada K; Kagawa H; Ohga R; Taira T; Fujimuro M
    Biol Pharm Bull; 2012; 35(5):725-30. PubMed ID: 22687408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.